These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 29991873)
1. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends. Mijan MA; Lim BO World J Gastroenterol; 2018 Jul; 24(25):2673-2685. PubMed ID: 29991873 [TBL] [Abstract][Full Text] [Related]
3. Nutritional Interventions Using Functional Foods and Nutraceuticals to Improve Inflammatory Bowel Disease. Shin DW; Lim BO J Med Food; 2020 Nov; 23(11):1136-1145. PubMed ID: 33047999 [TBL] [Abstract][Full Text] [Related]
4. Potential role of nutraceutical compounds in inflammatory bowel disease. Larussa T; Imeneo M; Luzza F World J Gastroenterol; 2017 Apr; 23(14):2483-2492. PubMed ID: 28465632 [TBL] [Abstract][Full Text] [Related]
5. Review of natural products actions on cytokines in inflammatory bowel disease. Hur SJ; Kang SH; Jung HS; Kim SC; Jeon HS; Kim IH; Lee JD Nutr Res; 2012 Nov; 32(11):801-16. PubMed ID: 23176791 [TBL] [Abstract][Full Text] [Related]
6. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review. Hashash JG; Elkins J; Lewis JD; Binion DG Gastroenterology; 2024 Mar; 166(3):521-532. PubMed ID: 38276922 [TBL] [Abstract][Full Text] [Related]
7. Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways. Huang Y; Zhang Y; Wan T; Mei Y; Wang Z; Xue J; Luo Y; Li M; Fang S; Pan H; Wang Q; Fang J Cell Biol Toxicol; 2021 Feb; 37(1):113-128. PubMed ID: 33130971 [TBL] [Abstract][Full Text] [Related]
8. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Debnath T; Kim DH; Lim BO Molecules; 2013 Jun; 18(6):7253-70. PubMed ID: 23783459 [TBL] [Abstract][Full Text] [Related]
9. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Hanai H; Sugimoto K Curr Pharm Des; 2009; 15(18):2087-94. PubMed ID: 19519446 [TBL] [Abstract][Full Text] [Related]
10. Diet and inflammatory bowel disease: review of patient-targeted recommendations. Hou JK; Lee D; Lewis J Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1592-600. PubMed ID: 24107394 [TBL] [Abstract][Full Text] [Related]
11. Saffron as a Promising Therapy for Inflammatory Bowel Disease. Rashid M; Rashid R; Saroya S; Deverapalli M; Brim H; Ashktorab H Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064796 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory pathways of importance for management of inflammatory bowel disease. Pedersen J; Coskun M; Soendergaard C; Salem M; Nielsen OH World J Gastroenterol; 2014 Jan; 20(1):64-77. PubMed ID: 24415859 [TBL] [Abstract][Full Text] [Related]
13. Role of Inflammation in the Development of Colorectal Cancer. Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590 [TBL] [Abstract][Full Text] [Related]
14. γ-Glutamyl cysteine and γ-glutamyl valine inhibit TNF-α signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor. Zhang H; Kovacs-Nolan J; Kodera T; Eto Y; Mine Y Biochim Biophys Acta; 2015 May; 1852(5):792-804. PubMed ID: 25558818 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of combination of platelet lysate and sulfasalazine administration in TNBS-induced colitis in rat. Yousefi-Ahmadipour A; Ebrahimi-Barough S; Niknia S; Allahverdi A; Mirzahosseini-Pourranjbar A; Tashakori M; Khajouee Ravari S; Asadi F; Heidari Barchi Nezhad R; Lotfibakhshaiesh N; Mirzaei MR Biomed Pharmacother; 2020 May; 125():109949. PubMed ID: 32058216 [TBL] [Abstract][Full Text] [Related]
16. Research progress in the treatment of inflammatory bowel disease with natural polysaccharides and related structure-activity relationships. Chen J; Gao Y; Zhang Y; Wang M Food Funct; 2024 Jun; 15(11):5680-5702. PubMed ID: 38738935 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in biological therapy for inflammatory bowel disease. Kurtovic J; Segal I Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463 [TBL] [Abstract][Full Text] [Related]
18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
19. Study of tumor necrosis factor receptor in the inflammatory bowel disease. Souza RF; Caetano MAF; Magalhães HIR; Castelucci P World J Gastroenterol; 2023 May; 29(18):2733-2746. PubMed ID: 37274062 [TBL] [Abstract][Full Text] [Related]
20. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. Lewis JD; Abreu MT Gastroenterology; 2017 Feb; 152(2):398-414.e6. PubMed ID: 27793606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]